Barclays Cuts MetLife (NYSE:MET) Price Target to $95.00

MetLife (NYSE:METGet Free Report) had its price objective lowered by research analysts at Barclays from $96.00 to $95.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. Barclays‘s price objective suggests a potential upside of 13.10% from the stock’s current price.

Several other research analysts have also commented on MET. TD Cowen lifted their price target on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. BMO Capital Markets assumed coverage on MetLife in a research report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target on the stock. JPMorgan Chase & Co. lifted their price target on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Wells Fargo & Company cut their price target on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 14th. Finally, StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $91.08.

Get Our Latest Report on MetLife

MetLife Stock Up 0.4 %

MET stock traded up $0.32 during trading on Friday, hitting $83.99. 4,184,790 shares of the company’s stock were exchanged, compared to its average volume of 3,774,320. The business has a 50-day moving average price of $83.80 and a two-hundred day moving average price of $80.73. The stock has a market capitalization of $58.16 billion, a price-to-earnings ratio of 16.93, a PEG ratio of 0.66 and a beta of 1.07. MetLife has a 52-week low of $66.18 and a 52-week high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.

MetLife (NYSE:METGet Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.01% and a net margin of 5.27%. As a group, equities research analysts expect that MetLife will post 8.18 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Atomi Financial Group Inc. boosted its position in MetLife by 44.4% during the third quarter. Atomi Financial Group Inc. now owns 6,090 shares of the financial services provider’s stock worth $502,000 after purchasing an additional 1,873 shares in the last quarter. CWM LLC boosted its position in MetLife by 15.0% during the third quarter. CWM LLC now owns 18,256 shares of the financial services provider’s stock worth $1,506,000 after purchasing an additional 2,383 shares in the last quarter. Marcum Wealth LLC boosted its position in MetLife by 12.0% during the third quarter. Marcum Wealth LLC now owns 3,785 shares of the financial services provider’s stock worth $312,000 after purchasing an additional 405 shares in the last quarter. Wedmont Private Capital boosted its position in MetLife by 2.5% during the third quarter. Wedmont Private Capital now owns 9,313 shares of the financial services provider’s stock worth $773,000 after purchasing an additional 228 shares in the last quarter. Finally, UMB Bank n.a. boosted its position in MetLife by 2.7% during the third quarter. UMB Bank n.a. now owns 6,756 shares of the financial services provider’s stock worth $557,000 after purchasing an additional 175 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

About MetLife

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.